Pliant Therapeutics, Inc. (PLRX)
$0.97-2.02%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $60M
- Beta
- 1.28
- P/E (TTM)
- -0.65
- Short % float
- 7.41%
- Days to cover
- 11.4
- SI change
- +15.0%
- 1W
- -5.83%
- 1M
- -15.65%
- vs SPY 1W
- -5.69%
- vs SPY 1M
- -18.16%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PLRX?
- LOPJLB’s latest quantitative signal on Pliant Therapeutics, Inc. (PLRX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PLRX in?
- Pliant Therapeutics, Inc. (PLRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Pliant Therapeutics, Inc. (PLRX) do?
- Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related diseases across the United States. Its flagship investigational product, PLN-74809, is an orally administered, small-molecule, dual-selective inhibitor targeting both avÃ6 and avÃ1 integrins, which…